[1].Siming Liu, Chuan Huang, Chunhui Huang, Yaqi Huang, Yonghuan Yu, Guowu Wu, Fengqiu Guo, Ying Jiang , Shanhe Wan, Zhengguang Zhu, Yuanxin Tian, Jianghua Zhu and Jiajie Zhang. Discovery of novel 2-aminopyridine derivatives as ROS1 and ALK dual inhibitors to combat drug-resistant mutants including ROS1G2032R and ALKG1202R. Journal of Enzyme inhibition and Medicinal Chemistry, 2023, 38(1) : 2227779. [2].Siming Liu, Ying Jiang, Ruohong Yan et al. Design, synthesis and biological evaluations of 2-amino-4-(1-piperidine) pyridine derivatives as novel anti crizotinib-resistant ALK/ROS1 dual inhibitors. European Journal of Medicinal Chemistry, 2019, 179: 358-379. [3].Siming Liu, Haikui Yang, Ying Jiang et al. Evolution strategy of ROS1 kinase inhibitors for use in cancer therapy. Future Medicinal Chemistry, 2018, 10(14), 1705-1720. |
